Poultry Diagnostics

Global Poultry Diagnostics Market to Reach US$878.8 Million by 2030

The global market for Poultry Diagnostics estimated at US$523.4 Million in the year 2024, is expected to reach US$878.8 Million by 2030, growing at a CAGR of 9.0% over the analysis period 2024-2030. ELISA, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$558.3 Million by the end of the analysis period. Growth in the PCR segment is estimated at 8.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$134.8 Million While China is Forecast to Grow at 12.3% CAGR

The Poultry Diagnostics market in the U.S. is estimated at US$134.8 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$201.5 Million by the year 2030 trailing a CAGR of 12.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.7% and 7.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.7% CAGR.

Global Poultry Diagnostics Market - Key Trends and Drivers Summarized

Poultry Diagnostics: Ensuring Health and Productivity in Poultry Farming

Poultry diagnostics involve the use of various tests and technologies to detect and monitor diseases in poultry flocks. These diagnostics are essential for ensuring the health and productivity of poultry, which are critical to the global food supply. Poultry diagnostics help in the early detection of infectious diseases, enabling timely interventions that prevent the spread of pathogens and reduce mortality rates. By monitoring the health status of flocks, poultry diagnostics support effective disease management and biosecurity measures, ensuring the safety and quality of poultry products. These diagnostics are crucial for maintaining animal welfare, optimizing production efficiency, and complying with regulatory standards, making them indispensable in modern poultry farming.

How Are Technological Advancements Enhancing Poultry Diagnostics?

Technological advancements have significantly improved the accuracy, speed, and convenience of poultry diagnostics. Innovations in molecular diagnostics, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), have enabled the rapid and precise detection of a wide range of pathogens, including viruses, bacteria, and parasites. The development of point-of-care diagnostic devices has facilitated on-site testing, providing immediate results and reducing the need for laboratory analysis. Advances in immunoassay technologies, such as enzyme-linked immunosorbent assay (ELISA), have improved the sensitivity and specificity of serological tests, enabling reliable detection of antibodies and antigens. Additionally, the integration of digital technologies and data analytics has enhanced the monitoring and management of poultry health, allowing for real-time tracking of disease outbreaks and informed decision-making. These technological innovations have transformed poultry diagnostics, making them more effective and accessible for farmers.

What Are the Key Benefits of Poultry Diagnostics?

Poultry diagnostics offer numerous benefits that enhance the health and productivity of poultry flocks. Diagnostic tests for avian influenza, Newcastle disease, and infectious bronchitis are essential for early detection and control of these highly contagious diseases, preventing significant economic losses. Routine monitoring of flock health through diagnostics helps identify and manage common bacterial infections, such as Salmonella and Mycoplasma, ensuring the safety of poultry products. Diagnostic tools also play a crucial role in vaccination programs, verifying the efficacy of vaccines and monitoring the immune status of flocks. The primary benefits of poultry diagnostics include improved disease control, enhanced biosecurity, and optimized production efficiency, contributing to the overall sustainability and profitability of poultry farming.

What Factors Are Driving the Growth in the Poultry Diagnostics Market?

The growth in the poultry diagnostics market is driven by several factors. The increasing prevalence of infectious diseases in poultry and the need for effective disease management are significant drivers, boosting the demand for advanced diagnostic tools. Technological advancements that enhance the accuracy, speed, and convenience of diagnostics are also propelling market growth. The rising awareness of animal welfare and the need for sustainable poultry production practices are driving the adoption of diagnostics that support early disease detection and preventive health measures. Additionally, the expansion of the poultry industry and the growing demand for high-quality poultry products are contributing to market growth. The increasing regulatory requirements for disease control and food safety are further boosting the demand for reliable poultry diagnostics. These factors, coupled with the increasing availability of innovative and cost-effective diagnostic solutions, are driving the sustained growth of the poultry diagnostics market.

SCOPE OF STUDY:

The report analyzes the Poultry Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Test (ELISA, PCR, Other Tests)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 23 Featured) -

• Affinitech, Ltd.
• Agrobiotek Internacional (Honduras)
• Aquila Diagnostic Systems Inc.
• Biochek BV
• Biogal, Galed Labs. Acs Ltd.
• Bioingentech Biotechnologies Inc.
• Bioneer Corporation
• Bionote, Inc.
• Boehringer Ingelheim International GmbH
• Clementia Biotech
• DRG Instruments GmbH
• GD Animal Health
• Idexx Laboratories, Inc.
• Idvet
• Life Bioscience Pty Ltd.
• Megacor Diagnostik GmbH
• Nisseiken Co., Ltd.
• Qiagen NV
• Thermo Fisher Scientific, Inc.
• Ubio Biotechnology Systems Pvt. Ltd.
• Zoetis, Inc.

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher. Show more